Among Idiopathic inflammatory myopathies, antisynthetase syndrome is meant to be rarely associated with cancer. However, clinical evidences of the association of those diseases led to the hypothesis that previous studies might have underestimated the prevalence of cancer in patients with antisynthetase syndrome. The aim of this study was to assess the prevalence of cancer in patients with antisynthetases syndrome in Grand Est and Bourgogne Franche-Comté regions.
Idiopathic inflammatory myopathies area heterogeneous group of disease involving mainly muscles, which paraneoplastic feature has been well characterized, specifically in some subgroups such as dermatomyositis. In contrast, antisynthetase syndrome is thought to be rarely associated with cancer. However, clinical observations of the association of those diseases led us to the hypothesis that previous studies might have underestimated the prevalence of cancer in patients with antisynthetase syndrome. The aim of this study was to assess the prevalence of cancer in patients with antisynthetases syndrome in Grand Est and Bourgogne Franche-Comté regions, describing the type of cancer observed as well as clinical features of patients and diagnostic work-up leading to the diagnosis of cancer.
Study Type
OBSERVATIONAL
Enrollment
200
Thomas Moulinet
Vandœuvre-lès-Nancy, Lorraine, France
RECRUITINGcancer prevalence
prevalence of cancer among patients with antisynthetase syndrome
Time frame: baseline
description of cancer type in patients with antisynthetase syndrome
description of the type and stage of cancer in patients with antisynthetase syndrome
Time frame: baseline
factors associated with cancer
comparison of clinical and paraclinical features associated with cancer in patients with antisynthetase syndrome
Time frame: baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.